The Australian report doesn't even mention the name PPL-1 or what it's being tested for. Hopeless. At least word is starting to get around. It's been interesting watching the breakout. Expected the fall back and have been watching for support around about this level. Still a dirt cheap entry point.
Ann: Juniper Pharma Services to reformulate MPL for Phase II, page-9
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.45M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.5¢ | 20.5¢ | $106.7K | 516.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 24033 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 55077 | 2 |
View Market Depth
| Last trade - 15.22pm 22/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |